AzTrials
AzTrials

Intellectual Developmental DisorderEmoTDINCT07303270

Emotional Processes in Adults With Intellectual Developmental Disorder

A study testing ACQUISS protocol assessing emotional processing. in people with Intellectual Developmental Disorder, run by Hôpital le Vinatier at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Emotions play a crucial part in the quality of life, interpersonal relationships and mental health in general. In adults presenting with intellectual developmental disorder (IDD), emotional abilities may be hindered, thus leading to more challenging behaviors. Read more about this study

Who is it for?
Ages 18 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Intellectual Developmental Disorder
What is being tested?
ACQUISS protocol assessing emotional processing.
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteFrance
Study dates
19 Feb 2026to 20 Nov 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • IDD group :
  • Diagnosis of IDD according to DSM-V criteria
  • aged between 18 and 3 years
  • French speaking
  • Membership or entitlement to a social security plan
  • informed consent, or that of the tutor, to take part in the study
Show all 12Show fewer
  • presence of a caregiver to complete the questionnaires at V2.
  • Control group :
  • aged between 18 and 35 years
  • French speaking
  • Membership or entitlement to a social security plan
  • Informed written consent to take part in the study.

Who cannot join

  • IDD group :
  • visual or auditory impairments, evaluated at V1
  • non stabilized epilepsy
  • undergoing treatments that can impact brain or psychological functioning
  • major motor disorders
  • breastfeeding or pregnant woman
Show all 14Show fewer
  • Control group :
  • neurodevelopmental or psychiatric disorder
  • history of brain trauma (TBI, stroke, etc…) or non-stabilized epilepsy
  • visual or auditory impairments, evaluated at V1
  • non stabilized epilepsy
  • undergoing treatments that can impact brain or psychological functioning
  • major motor disorders
  • breastfeeding or pregnant woman

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • CH Le Vinatier

    Bron, 69500

    Marie-Noelle Babinet, PhD, +33437915380, marie-noelle.babinet@ch-le-vinatier.fr

    Recruiting

Other trials in France

About this study

Official title: Assessing Emotional Processes in Adults With Intellectual Developmental Disorder Using the ACQUISS Battery

Emotions play a crucial part in the quality of life, interpersonal relationships and mental health in general. In adults presenting with intellectual developmental disorder (IDD), emotional abilities may be hindered, thus leading to more challenging behaviors. A better understanding of emotional processes of adults with IDD may help improve the efficiency of behavioral interventions and better improve their quality of life.

The primary goal of this study is to better characterize the abilities and weaknesses of adults with IDD concerning their emotional processes, in comparison to a healthy population. The secondary goals are :

  • to determine if these difficulties are underlined by oculomotor and attention (auditory and visual) processes
  • to determine if behavioral difficulties, as reported by the families of adults with IDD, are underlined by specific difficulties in facial emotion recognition, emotion identification in context and/or identification of vocal emotions.
Read the detailed description

The study will be carried out in 3 steps :

Step 1: All participants will undergo tests to evaluate their intellectual abilities, and auditory and visual screening tests.

Step 2 : All participants will undergo neuropsychological tests assessing attentional and oculomotor abilities (1 hour). During this time, the participant's family member will complete the questionnaires assessing behavior.

Step 3 : All participants will undergo the experimental ACQUISS protocol (task 1 : faces; task 2 : faces in context; task 3 : prosody) (1 hour).

Detailed Description:

Step 1 :

During this first step, all participants (both groups), will undergo the Raven Progressive Matrices (John and Raven 2003) to assess their intellectual abilities. They will then undergo an auditory screening test (tonality test) and a visual screening task (the Rossano-Weiss scale and the Palettes de Léa Grattins task).

Step 2 :

During this second step, all participants (both groups) will undergo :

  1. - the tangled lines test (Rey, 1964) : in this task, the participant must follow by gaze entangled lines to determine the beginning and end of each line.
  2. - the NSUCO oculomotor test (Maillet, 2015) : the orthoptist will evaluate the ability of the participant to carry out ocular saccades and movement pursuit.
  3. - the Auditory attention task of the NEPSY-II battery (Korkman et al., 2012)
  4. - 2 cancellation tests from the EVA battery (Chokron, 2010):
  • the TeddyBear Cancellation test
  • the single-letter cancellation test

Step 3:

During this step, all participants from both groups will undergo the ACQUISS protocol.

Being tested
ACQUISS protocol assessing emotional processing.
Keywords
Intellectual Developmental Disorder, emotional processing, Cognitive assessments, Social cognition
Medical subject headings
Intellectual Disability

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ACQUISS protocol assessing emotional processing.Other

    Task 1: 5 minute facial emotion recognition test to identify isolated facial expressions. 6 drawn faces, without gender bias, without hair, expressing the 6 universal emotions will be presented. The emotions are: happiness, sadness, anger, fear, surprise and disgust.

    Task 2 : identifying a character's emotion in a social context (20 min). The subject is presented with drawn social contexts, one character is always in orange, and the face is left blank. The subject then has to choose amongst 6 emotions (happiness, sadness, anger, fear, surprise and disgust) which one would correspond the most to the emotion expressed by the character in orange.

    Task 3 : recognizing vocal emotions (15 min). The subject is presented with dialogues of 3 sentences. The 3 sentences are expressed with a vocal emotion (same emotion for the 3 sentences). The contents of the sentences are neutral At the end of each dialogue, the subject has to show which emotion was expressed.

Study groups in NCT07303270
Study groupRoleWhat they receive
IDD groupExperimentaladults with Intellectual Developmental Disorder
Receives: Other: ACQUISS protocol assessing emotional processing.
Control groupOtherhealthy adults
Receives: Other: ACQUISS protocol assessing emotional processing.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. proportion of correct answers on the ACQUISS battery

    proportion of correct answers in each of the 3 tasks

    Measured: Baseline

Secondary outcomes (7)
  1. Proportion of correct answers on the Entangled lines test

    Measured: Baseline

  2. Proportion of correct answers on the NSUCO test

    Northeastern State University College of Optometry test.

    Measured: Baseline

  3. Proportion of correct answers on an auditory attentional task (NEPSY-II)

    Measured: Baseline

  4. Proportion of correct signs barred on the TeddyBear task

    Measured: Baseline

  5. Proportion of correct signs barred on the letter task

    Measured: Baseline

  6. Score on the Agressivity questionnaire

    Score on the Agressivity questionnaire ("Problematic behavior in group settings"), filled in by a caregiver. Minimum score = 6; Maximum score = 30. Higher scores suggest greater agressivity.

    Measured: Baseline

  7. Score on the Aberrant Behavior Checklist

    Score on the Aberrant Behavior Checklist, filled in by a caregiver. Minimum = 0; Maximum = 174. Higher scores reflect more severe levels of challenging behavior.

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Dec 2025
  2. Study start19 Feb 2026
  3. Primary completionAug 2028 (estimated)
  4. Study completion20 Nov 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
IDD group compared to control group
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07303270
Sponsor's protocol ID
2025-A01946-43
Acronym
EmoTDI
Status last verified
Mar 2026
First submitted
11 Dec 2025
Last updated
1 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing ACQUISS protocol assessing emotional processing. in people with Intellectual Developmental Disorder, run by Hôpital le Vinatier at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 1 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Marie-Noelle Babinet, PhD (+33437915380, marie-noelle.babinet@ch-le-vinatier.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

proportion of correct answers on the ACQUISS battery (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in